PharMerica (PMC) Scheduled to Post Quarterly Earnings on Thursday

PharMerica (NYSE:PMC) is scheduled to issue its quarterly earnings data on Thursday, February 22nd. Analysts expect the company to announce earnings of $0.55 per share for the quarter.

PharMerica (NYSE PMC) opened at $29.25 on Thursday. PharMerica has a 1 year low of $22.00 and a 1 year high of $29.50. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.79 and a current ratio of 2.58. The stock has a market cap of $910.27, a P/E ratio of 47.95, a price-to-earnings-growth ratio of 1.27 and a beta of 0.82.

Separately, ValuEngine raised shares of PharMerica from a “hold” rating to a “buy” rating in a report on Tuesday, October 31st. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $30.50.

In other PharMerica news, CEO Gregory S. Weishar sold 521,089 shares of the business’s stock in a transaction dated Thursday, December 7th. The shares were sold at an average price of $29.25, for a total transaction of $15,241,853.25. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 5.04% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “PharMerica (PMC) Scheduled to Post Quarterly Earnings on Thursday” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at

About PharMerica

PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.

Earnings History for PharMerica (NYSE:PMC)

Receive News & Ratings for PharMerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharMerica and related companies with's FREE daily email newsletter.

Leave a Reply